WAG lags after the loss of Express Scripts, but acquiring Rite Aid could restore its health. More
ESRX
Recent Articles
Green Mountain Coffee Grounded — Wednesday’s IP Market Recap
After a lackluster day for the markets, Green Mountain set off fireworks with disappointing K-Cup sales and a lowered forecast that sent GMCR shares plunging. More
CVS Earnings Rise Along With a Longer Sniffle Season
CVS revenues and earnings came in ahead of analyst estimates as the company benefited from an acquisition and the migration of customers from Walgreens. More
Analysts Run the Apple Asylum — Tuesday’s IP Market Recap
Price targets keep climbing to the moon: $715, $910 -- even $1,001. More
The Perfect Prescription for Profits
There’s a lot to be said for going with the category killer in an investment. A merger is creating exactly that in the prescription service space. More
Walgreens Declares a Twitter War on Express Scripts
Walgreens somehow thinks a war on Twitter will repair the damage from losing a key partner, Express Scripts. More
Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?
CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns. More
